参考文献/References:
[1] Sun T,Han X.Death versus dedifferentiation:the molecular bases of beta cell mass reduction in type 2 diabetes[J].Semin Cell Dev Biol,2020,103:76-82.DOI:10.1016/j.semcdb.2019.12.002.
[2] LaPierre MP,Stoffel M.MicroRNAs as stress regulators in pancreatic beta cells and diabetes[J].Mol Metab,2017,6(9):1010-1023.DOI:10.1016/j.molmet.2017.06.020.
[3] Ho PTB,Clark IM,Le LTT.MicroRNA-based diagnosis and therapy[J].Int J Mol Sci,2022,23(13):7167.DOI:10.3390/ijms23137167.
[4] Grieco GE,Brusco N,Licata G,et al.The landscape of microRNAs in β Cell:between phenotype maintenance and protection[J].Int J Mol Sci,2021,22(2):803.DOI:10.3390/ijms22020803.
[5] Jonas JC,Sharma A,Hasenkamp W,et al.Chronic hyperglycemia triggers Loss of pancreatic beta cell differentiation in an animal model of Diabetes[J].J Biol Chem,1999,274(20):14112-14121.DOI:10.1074/jbc.274.20.14112.
[6] Cinti F,Bouchi R,Kim-Muller JY,et al.Evidence of β-Cell dedifferentiation in human type 2 diabetes[J].J Clin Endocrinol Metab,2016,101(3):1044-1054.DOI:10.1210/jc.2015-2860.
[7] Amo-Shiinoki K,Tanabe K,Hoshii Y,et al.Islet cell dedifferentiation is a pathologic mechanism of long-standing progression of type 2 diabetes[J].JCI insight,2021,6(1):e143791.DOI:10.1172/jci.insight.143791.
[8] Wang W,Zhang C.Targeting β-cell dedifferentiation and transdifferentiation:opportunities and challenges[J].Endocr Connect,2021,10(8):R213-R228.DOI:10.1530/EC-21-0260.
[9] Latreille M,Hausser J,Stützer I,et al.MicroRNA-7a regulates pancreatic β cell function[J].J Clin Invest,2014,124(6):2722-2735.DOI:10.1172/JCI73066.
[10] Zhu Y,Sun Y,Zhou Y,et al.MicroRNA-24 promotes pancreatic beta cells toward dedifferentiation to avoid endoplasmic reticulum stress-induced apoptosis[J].J Mol Cell Biol,2019,11(9):747-760.DOI:10.1093/jmcb/mjz004.
[11] Yang L,Zhu Y,Kong D,et al.EGF suppresses the expression of miR-124a in pancreatic β cell lines via ETS2 activation through the MEK and PI3K signaling pathways[J].Int J Biol Sci,2019,15(12):2561-2575.DOI:10.7150/ijbs.34985.
[12] Grieco GE,Brusco N,Fignani D,et al.Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation[J].Cell Death Discov,2022,8(1):340.DOI:10.1038/s41420-022-01142-x.
[13] Gaddam RR,Kim YR,Li Q,et al.Genetic deletion of miR-204 improves glycemic control despite obesity in db/db mice[J].Biochem Biophys Res Commun,2020,532(2):167-172.DOI:10.1016/j.bbrc.2020.08.077.
[14] Sun F,Sun Y,Wu F,et al.Mesenchymal stem cell-derived extracellular vesicles:a potential therapy for diabetes mellitus and diabetic complications[J].Pharmaceutics,2022,14(10):2208.DOI:10.3390/pharmaceutics14102208.
[15] Xu Y,Tang Z,Dai H,et al.MiR-195 promotes pancreatic β-cell dedifferentiation by targeting Mfn2 and impairing Pi3k/Akt signaling in type 2 diabetes[J].Obesity(Silver Spring),2022,30(2):447-459.DOI:10.1002/oby.23360.
[16] Sebastiani G,Grieco GE,Brusco N,et al.MicroRNA expression analysis of In vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s[J].Int J Mol Sci,2018,19(4):1170.DOI:10.3390/ijms19041170.
[17] Wang Z,Mohan R,Chen X,et al.MicroRNA-483 protects pancreatic β-Cells by targeting ALDH1A3[J].Endocrinology,2021,162(5):bqab031.DOI:10.1210/endocr/bqab031.
[18] Kretzschmar K,Clevers H.Wnt/β-catenin signaling in adult mammalian epithelial stem cells[J].Dev Biol,2017,428(2):273-282.DOI:10.1016/j.ydbio.2017.05.015.
[19] Liu XS,Fan B,Szalad A,et al.MicroRNA-146a mimics reduce the peripheral neuropathy in type 2 diabetic mice[J].Diabetes,2017,66(12):3111-3121.DOI:10.2337/db16-1182.
[20] Shan L,Zhang H,Han Y,et al.Expression and mechanism of microRNA 195 in diabetic retinopathy[J].Endocr J,2022,69(5):529-537.DOI:10.1507/endocrj.EJ21-0231.
[21] Zhu LL,Wang HY,Tang T.Effects of miR-195 on diabetic nephropathy rats through targeting TLR4 and blocking NF-κB pathway[J].Eur Rev Med Pharmacol Sci,2021,25(3):1522-1529.DOI:10.26355/eurrev_202102_24860.
[22] Georgiadou E,Muralidharan C,Martinez M,et al.Mitofusins mfn1 and mfn2 are required to preserve glucose-but not incretin-stimulated β-Cell connectivity and insulin secretion[J].Diabetes,2022,71(7):1472-1489.DOI:10.2337/db21-0800.
[23] Zhu H,Leung SW.MicroRNA biomarkers of type 2 diabetes:evidence synthesis from meta-analyses and pathway modelling[J].Diabetologia,2023,66(2):288-299.DOI:10.1007/s00125-022-05809-z.
[24] Eliasson L,Esguerra JLS.MicroRNA networks in pancreatic islet cells:normal function and type 2 diabetes[J].Diabetes,2020,69(5):804-812.DOI:10.2337/dbi19-0016.
[25] Palihaderu P,Mendis B,Premarathne J,et al.Therapeutic potential of miRNAs for type 2 diabetes mellitus:an overview[J].Epigenetics Insights,2022,15:25168657221130041.DOI:10.1177/25168657221130041.
相似文献/References:
[1]李新萍,张萍,李晓玉.螺内酯对特发性醛固酮增多症患者胰岛β细胞功能的影响[J].国际内分泌代谢杂志,2014,(06):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
Li Xinping,Zhang Ping,Li Xiaoyu..Effects of spironolactone on islet β cell function in patients with idiopathic hyperaldosteronism[J].International Journal of Endocrinology and Metabolism,2014,(01):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
[2]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[3]任寒,王恺,丁元林,等.miR-375与2型糖尿病[J].国际内分泌代谢杂志,2014,(05):330.[doi:10.3760/cma.j.issn.1673-4157.2014.05.012]
Ren Han*,Wang Kai,Ding Yuanlin,et al.Relationship between miR-375 and type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2014,(01):330.[doi:10.3760/cma.j.issn.1673-4157.2014.05.012]
[4]Ming Liu,Jinhong Sun,Jingqiu Cui,等.胰岛素基因突变: 从遗传学和β细胞
生物学到临床疾病[J].国际内分泌代谢杂志,2016,36(02):128.[doi:10.3760/cma.j.issn.1673-4157.2016.02.013]
[5]陈煜,曹萌,刘超.自噬在2型糖尿病中的作用[J].国际内分泌代谢杂志,2016,36(05):346.[doi:10.3760/cma.j.issn.1673-4157.2016.05.16]
Chen Yu,Cao Meng,Liu Chao.Role of autophagy in type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(01):346.[doi:10.3760/cma.j.issn.1673-4157.2016.05.16]
[6]薛静静,王彦.替米沙坦保护胰岛β细胞功能的研究进展[J].国际内分泌代谢杂志,2017,37(01):42.[doi:10.3760/cma.j.issn.1673-4157.2017.01.12]
Xue Jingjing,Wang Yan..Research progress in protecting islet β cell function of telmisartan[J].International Journal of Endocrinology and Metabolism,2017,37(01):42.[doi:10.3760/cma.j.issn.1673-4157.2017.01.12]
[7]朱海娇,王幸,陈树春,等.SERCA2b与胰岛β细胞功能[J].国际内分泌代谢杂志,2017,37(06):411.
Zhu Haijiao,Wang Xing,Chen Shuchun,et al.SERCA2b and the function of islet β cells[J].International Journal of Endocrinology and Metabolism,2017,37(01):411.
[8]薛君力 代喆 曾姣娥 徐焱成.RIP140在姜黄素抑制MIN6细胞凋亡中的
作用机制[J].国际内分泌代谢杂志,2018,38(03):154.[doi:10.3760/cma.j.issn.1673-4157.2018.03.003]
Xue Junli*,Dai Zhe,Zeng Jiao'e,et al.Role of RIP140 in the inhibition of curcumin on apoptosis in MIN6 cells[J].International Journal of Endocrinology and Metabolism,2018,38(01):154.[doi:10.3760/cma.j.issn.1673-4157.2018.03.003]
[9]袁叶青 包玉倩.外泌体参与糖尿病发生的机制研究[J].国际内分泌代谢杂志,2018,38(02):102.[doi:10.3760/cma.j.issn.1673-4157.2018.02.008]
Yuan Yeqing,Bao Yuqian.Researches on the mechanism of exosomes in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(01):102.[doi:10.3760/cma.j.issn.1673-4157.2018.02.008]
[10]钱瑶 曾姣娥 薛君力.白细胞介素-22与2型糖尿病及其并发症[J].国际内分泌代谢杂志,2019,39(05):337.[doi:10.3760/cma.j.issn.1673-4157.2019.05.012]
Qian Yao,Zeng Jiao'e,Xue Junli.Interleukin-22, type 2 diabetes mellitus and its complications[J].International Journal of Endocrinology and Metabolism,2019,39(01):337.[doi:10.3760/cma.j.issn.1673-4157.2019.05.012]